<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364381">
  <stage>Registered</stage>
  <submitdate>6/06/2013</submitdate>
  <approvaldate>24/03/2015</approvaldate>
  <actrnumber>ACTRN12615000277549</actrnumber>
  <trial_identification>
    <studytitle>Non-randomised pilot study of a text message self-management support programme for people with diabetes</studytitle>
    <scientifictitle>Non-randomised pilot study on the acceptability and efficacy of a text message self-management support programme for people with diabetes</scientifictitle>
    <utrn />
    <trialacronym>SMS4BG</trialacronym>
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>diabetes</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>An automated tailored text messaging programme with self-selected modules. A core programme of motivational support messages (2/week) in Maori or non-Maori versions; add-on modules include blood glucose monitoring reminders at a selected frequency (from 1/week to 4/day); insulin information (1/week); adolescent messages (1/week); self-selected goals around healthy eating, physical activity or stress/mood management (start at 4/week and reduce in frequency). The three month programme aims to support and enhance self-management of diabetes and other wellness goals between clinic visits</interventions>
    <comparator>NA - This is a single group study control </comparator>
    <control>Uncontrolled</control>
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>HbA1c laboratory tests in the past 12 months at baseline and HbA1c laboratory tests after the programme</outcome>
      <timepoint>At baseline and at the end of the text message programme (3 months)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Participant satisfaction - via open ended questions developed specifically for this study</outcome>
      <timepoint>at 3 months after the start of the programme</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Sense of control - via open ended question designed for this study</outcome>
      <timepoint>3 months after the start of the programme</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Blood glucose monitoring - self-reported via open ended question</outcome>
      <timepoint>over the course of the 3 month programme</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>clinician satisfaction - a satisfaction questionnaire will be developed by researchers</outcome>
      <timepoint>at 3 months after the start of the programme</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>type 1 or type 2 diabetes
16-65 years
on insulin
HbA1c greater than 70
have a mobile phone</inclusivecriteria>
    <inclusiveminage>16</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Not available for the duration of the programme</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Educational / counselling / training</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>Participants will receive a participant information sheet explaining the study purpose and procedures from the 
Doctor or nurse in charge of their diabetes care. They will be given the opportunity to ask questions and time to 
discuss participation with their family/whanau. They will be given the opportunity to contact the research team for 
further information. Consent to receive the text messages will be given via text 'I consent'. A researcher will contact 
the participant to discuss participation in the evaluation component, questions will be answered and the participant 
will be given time to consider. Verbal consent will be obtained and a copy of the consent form posted to the 
participant.</concealment>
    <sequence>no randomisation</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Descriptive statistics will be used to describe the change in HbA1c over 3 months. Qualitative feedback will be reported using a general thematic analysis.</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>16/07/2013</anticipatedstartdate>
    <actualstartdate>22/07/2013</actualstartdate>
    <anticipatedenddate>31/08/2013</anticipatedenddate>
    <actualenddate>26/08/2013</actualenddate>
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Waitemata District Health Board</primarysponsorname>
    <primarysponsoraddress>15 Shea Terrace
Takapuna
Auckland 0622</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Waitemata District Health Board</fundingname>
      <fundingaddress>15 Shea Terrace
Takapuna
Auckland 0622</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>National Institute for Health Innovation</sponsorname>
      <sponsoraddress>School of Population Health Tamaki Campus University of Auckland Private Bag 92019 Auckland 1142</sponsoraddress>
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This pilot study will assess the acceptability and efficacy of a text message theory-based self-management support programme that aims to enhance control of diabetes. </summary>
    <trialwebsite />
    <publication>Dobson, R., Carter, K., Cutfield, R., Hulme, A., Hulme, R., McNamara, C., Maddison, R., Murphy, R., Shepherd, M., Strydom, J., &amp; Whittaker, R. Diabetes Text-Message Self-Management Support Program (SMS4BG): A Pilot Study. JMIR mHeatlh and uHealth (in press)</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Auckland Human Subjects Ethics Committee</ethicname>
      <ethicaddress>University of Auckland
Private Bag 92019
Auckland 1142</ethicaddress>
      <ethicapprovaldate>7/05/2013</ethicapprovaldate>
      <hrec>13/NTA/55</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Robyn Whittaker</name>
      <address>National Institute for Health Innovation
University of Auckland
Private Bag 92019
Auckland 1142</address>
      <phone>+6499234766</phone>
      <fax />
      <email>r.whittaker@nihi.auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Robyn Whittaker</name>
      <address>National Institute for Health Innovation
University of Auckland
Private Bag 92019
Auckland 1142</address>
      <phone>+6499234766</phone>
      <fax />
      <email>r.whittaker@nihi.auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Robyn Whittaker</name>
      <address>National Institute for Health Innovation
University of Auckland
Private Bag 92019
Auckland 1142</address>
      <phone>+6499234766</phone>
      <fax />
      <email>r.whittaker@nihi.auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Robyn Whittaker</name>
      <address>National Institute for Health Innovation
University of Auckland
Private Bag 92019
Auckland 1142</address>
      <phone>+6499234766</phone>
      <fax />
      <email>r.whittaker@nihi.auckland.ac.nz</email>
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>